VIA
GOSS icon

Vickerman Investment Advisors’s Gossamer Bio GOSS Stock Holding History

Vickerman Investment Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.73K Hold
34,787
– – ﹤0.01% 100
2026
Q1 		$11.4K Hold
34,787
– – ﹤0.01% 94
2025
Q4 		$108K Buy
+34,787
New +$99.3K 0.02% 89

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Vickerman Investment Advisors's GOSS Position: Q2 2026 in Review

Vickerman Investment Advisors held its Gossamer Bio (GOSS) position steady in Q2 2026 at 34,787 shares worth $5.73K. The position accounts for ﹤0.01% of the portfolio, ranked #100.

Vickerman Investment Advisors first reported a position in GOSS in Q4 2025 and has held it in 3 quarters since. The position peaked at $108K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Vickerman Investment Advisors held 34,787 shares of Gossamer Bio worth $5.73K as of Q2 2026.
  • Vickerman Investment Advisors left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of Vickerman Investment Advisors's portfolio in Q2 2026, its #100 holding.
  • Vickerman Investment Advisors first reported a position in Gossamer Bio in Q4 2025 and has held it in 3 quarters since.
  • Vickerman Investment Advisors's Gossamer Bio position peaked at $108K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Vickerman Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.